- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2017 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year

CITE Title : Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year Personal Author(s) : Kroll-Desrosiers, Aimee R.;Nephew, Benjamin C.;Babb, Jessica A.;Guilarte-Walker, Yurima;Moore Simas, Tiffany A.;Deligiannidis, Kristina M.; Published Date : 2 2017;2-2017; Source : Depress Anxiety. 34(2):137-146 URL : https://stacks.cdc.gov/view/cdc/44260 Kroll-Desrosiers, Aimee R. et al. (2017). Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year. 34(2). Kroll-Desrosiers, Aimee R. et al. "Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year" 34, no. 2 (2017) Kroll-Desrosiers, Aimee R. et al. "Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year" vol. 34, no. 2, 2017 Export RIS Citation Information.

:

Kroll-Desrosiers, Aimee R. ;

Nephew, Benjamin C.

2 2017 | Depress Anxiety. 34(2):137-146

:

BackgroundDue to its potent effects on social behavior, including maternal behavior, oxytocin has been identified as a potential mediator of postpartu...

To see more results, try removing search filters or changing the search terms